Significance of pretreatment hemoglobin level in patients with T1 glottic cancer

Radiation Oncology Investigations

Volumn 7, Issue 1, 1999, Pages 42-48

  Canaday, Daniel J ^a,d   Regine, William F ^b   Mohiuddin, Mohammed ^b   Zollinger, William ^b   Machtay, Mitchell ^a   Lee, Jason ^a   Schultz, Delray ^a   Rudoltz, Marc S ^a,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c St Vincent's Medical Center Jacksonville   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Glottic cancer; Hemoglobin; Laryngeal cancer; Radiation therapy

Indexed keywords

HEMOGLOBIN;

ADULT; AGE; AGED; ANTERIOR COMMISSURE; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HUMAN; HYPOXEMIA; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

ACTUARIAL ANALYSIS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HEMOGLOBINS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; TIME FACTORS;

EID: 0032995706     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:1<42::AID-ROI6>3.0.CO;2-W     Document Type: Article

References (25)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1998. CA Cancer J Clin 1998;48:6-29.
2. Woodhouse RJ, Quivey JM, Fu KK, Sien PS, Dedo HH, Phillips T. Treatment of carcinoma of the vocal cord: A review of 20 years experience. Laryngoscope 1981;9:1155-1162.
3. Rudoltz MS, Benammar A, and Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 1995;26:767-772.
4. Schwaibold F, Scariato A, Nunno M, Wallner PE, Lustig RA, Rouby E, et al. The effect of fraction size on control of early glottic cancer. Int J Radiat Oncol Biol Phys 1988;14:451-454.
5. Stevenson J, Juillard G, Selch M. Stages 1 and 2 epidermoid carcinoma of the glottic larynx: involvement of the anterior commissure. Radiol 1992;182:797-799.
6. Mendenhall WM, Parsons JT, Million RR. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: Relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys 1988;15:1267-1273.
7. Overgaard J, Hansen HS, Jorgensen K, Hjelm Hansen M. Primary radiotherapy of larynx and pharynx carcinoma-an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys 1986; 12:515-522.
8. Johansen LV, Overgaard J, Hjelm-Hansen M, Gadeberg CC. Primary radiotherapy of T1l squamous cell carcinoma of the larynx: Analysis of 478 patients treated from 1963 to 1985. Int J Radiat Oncol Biol Phys 1990;18:1307-1313.
9. Olszewski SJ, Vaeth JM, Green JP, Schroeder AF, Chauser B. The influence of field size, treatment modality, commissure involvement and histology in the treatment of early vocal cord cancer with irradiation. Int J Radiat Oncol Biol Phys 1985;11:1333-1357.
10. Wang CC, Efird JT. Does prolonged treatment course adversely affect local control of carcinoma of the larynx? Int J Radiat Oncol Biol Phys 1994;29:657-660.
11. Hayakawa K, Misuhashi N, Tamaki Y, Takahashi M, Honjo J, Kamei T et al. Radiation therapy for stage I and II laryngeal cancer using 10 MV X-rays or Cobalt-60 gamma rays. Rad Med 1992;10:199-205.
12. Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ Jr, et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995; 13:2077-2083.
13. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assn 1958;53:457-481.
14. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons; 1980.
15. Cox, D. Regression models and life tables. J R Stat Soc 1972;34:1870-220.
16. Hall EJ. Radiobiology for the Radiologist. Philadelphia: J.B. Lipincott Co; 1994. p 133-152.
17. Lartigau E, Le Ridant A, Lambin P, Weeger P, Martin L, Sigal R, et al. Oxygenation of head and neck tumors. Cancer 1993;71:2319-2325.
18. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988;14:831-838.
19. Nordsmaark M, Overgaard M, Overgaard J. Oxygenation status predicts radiation response in advanced squamous cell carcinoma of the head and neck. (Abstract) Eur J Cancer 1995;31A:S103.
20. Brizel, DM, Sibley GS, Prosnitz, LR, Scher RL, Dewhirst, MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38285-38228.
21. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-943.
22. Hockel M, Vorndran B, Schlenger K, Baussmann E, Knapstein PG. Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 1993;51:141-149.
23. Warde PR, O'Sullivan B, Panzarella T, Keane TJ, Gullane P, Payne D, et al. T1/T2 glottic cancer managed by external beam radiotherapy - the influence of pretreatment hemoglobin on local control (Abstract). Int J Radiat Oncol Biol Phys Proc ASTRO 1996;36: 336.
24. Sakata K, Yukimasa A, Karasawa K, Hasezawa K, Muta N, Nakagawa K, et al. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control. Int J Radiat Oncol Biol Phys 1994;30:1059-1064.
25. Tucker JC, Hixson WC, Kim RY. Pretreatment hemoglobin in early stage glottic cancer: Red flag or red herring? (Abstract). Int J Oncol Biol Phys Proc ASTRO 1996;36:336.